FDA Advisory Committee Votes in Favor of Pfizers MYLOTARG (gemtuzumab ozogamicin) for Acute Myeloid Leukemia
admin 14th July 2017 Uncategorised 0Pfizer
More: FDA Advisory Committee Votes in Favor of Pfizers MYLOTARG (gemtuzumab ozogamicin) for Acute Myeloid Leukemia
Source: MDlinx